The Influence of Hydrocolloid Patch Composition on the Bioavailability of Triamcinolone Acetonide in Humans

REFERENCES

• Wiechers J. W. The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm. Weekbl. Sci. Ed. 1989; 11: 185–198
   PubMedGoogle Scholar
• Hollingsbee D. A., Martin G. P., Monger L., Marriott C., Fairbrother J. E. The effect of hydrocolloid dermatological patch (Actiderm) in potentiating the skin activity of triamcinolone acetonide. Int. J. Pharm. 1991; 77: 199–209
   Google Scholar
• Hollingsbee D. A., Martin G. P., Walker M., Marriott C., Fairbrother J. E. The effect of semi-permeable film covers on the bioavailability of betamethasone valerate delivered from a topical cream [abstract]. J. Pharm. Pharmacol. 1990; 42: 160P
   Google Scholar
• Ladenheim D., Monger L. S., Edwardson P. A. D., Hollingsbee D. A., Martin G. P., Marriott C., Lloyd A. W. The effect of dermatological patch on stratum corneum hydration and percutaneous absorption. Proc. Int. Symp. Controlled Release Bioactive Mater. 1992; 19: 460–461
   Google Scholar
• Ladenheim D., Edwardson P. A. D., Walker M., Martin G. P., Marriott C., Lloyd A. W. The assessment of skin hydration produced by occlusion using Fourier transform infrared spectroscopy [abstract]. J. Pharm. Pharmacol. 1991; 43: 58P
   PubMedGoogle Scholar
• Kadir R., Barry B. W., Fairbrother J. E., Hollingsbee D. A. Delivery of triamcinolone acetonide through human epidermis: effect of Actiderm, a new hydrocolloid dermatological patch. Int. J. Pharm. 1990; 60: 139–145
   Google Scholar
• Marriott C., Martin G. P. Preclinical results of a new hydrocolloid patch used in conjunction with topical corticosteroids in inducing the blanching response. Beyond Occlusion: Dermatology Proceedings, T. J. Ryan. Royal Society of Medicine Services, London 1988; 9–18
   Google Scholar
• Nielsen P. G., Madsen S. M. Occlusive treatment of palmoplantular postular psoriasis with clobetasol propionate ointment succeeded by short term PUVA. J. Derm. Treatment 1995; 6: 77–79
   Web of Science ®Google Scholar
• Montenegro L., Ademola J. I., Bonina E. P., Maibach H. I. Effect of application time of betamethasone-17-valerate 0.1% cream on skin blanching and stratum corneum drug concentration. Int. J. Pharm. 1996; 140: 51–60
   Web of Science ®Google Scholar
• Thewes M., Bright R. Use of hydrocolloid dressing in combination with a topical steroid in plaques psoriasis. Cutis 1996; 57: 48–50
   PubMed Web of Science ®Google Scholar
• Van de Kerkhoff P. C. M., Chang A., Ven der Walle H. B., Vlijmen-Willems I. Van, Boezeman J. B. M., Huigen-Tijdink R. Weekly treatment of psoriasis with a hydrocolloid dressing in combination with triamcinolone acetonide. Acta Derm. Venereol. (Stockholm) 1994; 74: 143–146
   PubMed Web of Science ®Google Scholar
• Beitner H. Treatment of hand dermatosis: a comparative study of topical glucocorticoid ointment versus solution occluded with a new thin hydrocolloid dressing. Acta Derm. Venereol. (Stockholm) 1996; 76: 408–409
   PubMed Web of Science ®Google Scholar
• Ladenheim D., Martin G. P., Marriott C., Hollingsbee D. A., Brown M. B. An in vitro study of the effect of hydrocolloid patch occlusion on the penetration of triamcinolone acetonide through skin in man. J. Pharm. Pharmacol. 1996; 48: 806–811
   PubMed Web of Science ®Google Scholar
• Cevc G., Blume G., Schatzlein A., Gebauer D., Paul A. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv. Drug Delivery Rev. 1996; 18: 349–378
   Web of Science ®Google Scholar
• McKenzie A. W., Stoughton A. W. Percutaneous absorption of steroids. Arch. Dermatol. 1962; 86: 611–614
   Web of Science ®Google Scholar
• Barry B. W., Southwell D., Woodford R. Optimization of biovailability of topical steroids: penetration enhancers under occlusion. J. Invest. Dermatol. 1984; 82: 49–52
   PubMed Web of Science ®Google Scholar
• Jackson D. B., Thompson C., McCormack J. R., Guin J. D. Bioequivalence (bioavailability) of generic corticosteroids. J. Am. Acad. Dermatol. 1989; 20: 791–796
   PubMed Web of Science ®Google Scholar
• Olsen E. A. A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay. Arch. Derm. 1991; 127: 197–201
   PubMed Web of Science ®Google Scholar
• Smith E. W., Meyer E., Haigh J. M. Blanching activities of betamethasone formulations. Arzneim.-Forsch. 1990; 40: 618–621
   PubMed Web of Science ®Google Scholar
• Caron D., Queille-Roussel C., Shah V. P., Schaeffer H. Correlation between the drug penetration and the blanching effect of topically applied hydrocortisone creams in human beings. J. Am. Acad. Dermatol. 1990; 23: 458–462
   PubMed Web of Science ®Google Scholar
• Hollingsbee D. A., Martin G. P., Marriott C., Fairbrother J. E. The use of alternative methods for conducting skin blanching (vasoconstriction) studies with topical corticosteroid products [abstract]. Pharm Res. 1990; 7: S50
   Google Scholar
• Ladenheim D., Monger L. S., Martin G. P., Marriott C., Hollingsbee D. A. The effect of hydrocolloid composition of a dermatological patch on hydration and corticosteroid induced blanching [abstract]. J. Pharm. Pharmacol. 1991; 43: 54
   PubMedGoogle Scholar
• Waring M. J., Monger L., Hollingsbee D. A., Martin G. P., Marriott C. Assessment of corticosteroid-induced skin blanching: evaluation of the Minola Chromometer CR200. Int. J. Pharm. 1993; 94: 211–222
   Google Scholar
• Aiache J. M., Lafaze C. L., Bouzat J., Rabier R. Evaluation de la diponibilité topique des corticoides par thermographie. J. Pharm. Belg. 1980; 35: 87–195
   Google Scholar
• Trikam D. S. K., Morton D. J. Development of an objective method for assessing topical corticosteroid efficacy. Cent. Afr. J. Med. 1985; 31: 228–229
   PubMedGoogle Scholar
• Queille-Roussel C., Poncet M., Schaefer H. Quantification of skin colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter. Br. J. Derm. 1991; 124: 264–270
   PubMed Web of Science ®Google Scholar
• Gibson J. R., Kirsch J. M. Relative potencies of topical corticosteroids. Br. J. Dermatol. 1986; 114: 638–639
   PubMed Web of Science ®Google Scholar
• Barry B. W. Optimizing percutaneous absorption. Percutaneous Absorption, R. L. Bronaugh, H. I. Maibach. Marcel Dekker, New York 1985; 489–513
   Google Scholar
• Barry B. W., Woodford R. Comparison of bio-availability and activity of proprietary topical corticosteroid preparations: vasoconstrictor assays on 31 ointments. Br. J. Dermatol. 1975; 93: 563–571
   PubMed Web of Science ®Google Scholar
• Barry B. W., Woodford R. Activity and bioavailability of topical steroids in vivo/in vitro correlation for the vasoconstrictor test. J. Clin. Pharm. 1978; 3: 43–65
   Web of Science ®Google Scholar
• Miller J. N., Miller J. C. Statistics for Analytical Chemistry. Wiley, New York 1986; 129–130
   Google Scholar
• Mali J. W. H. The transport of water through human epidermis. J. Invest. Dermatol. 1956; 27: 451–469
   PubMed Web of Science ®Google Scholar
• Grice K., Sattar H., Sharratt M., Baker H. Skin temperature and transepidermal water loss. J. Invest. Dermatol. 1971; 57: 108–110
   PubMed Web of Science ®Google Scholar
• Aly R., Shirley C., Cunico B., Maibach H. I. Effect of prolonged occlusion on the microbial flora, pH, carbon dioxide and transepidermal water loss on human skin. J. Invest. Dermatol. 1978; 71: 378–381
   PubMed Web of Science ®Google Scholar
• Rietschel R. L. A method to evaluate skin moisturizers in vivo. J. Invest. Dermatol. 1978; 70: 152–155
   PubMed Web of Science ®Google Scholar
• Murahata R. I., Crowe D. M., Roheim J. R. The use of transepidermal water loss to measure and predict the irritation response to surfactants. Int. J. Cosmet. Sci. 1986; 8: 225–231
   PubMed Web of Science ®Google Scholar
• Lotte C., Rougier A., Wilson D. R., Maibach H. I. In vivo relationship between transepidermal water loss and percutaneous penetration of some organic compounds in man: effect of anatomic site. Arch. Dermatol. Res. 1987; 279: 351–356
   PubMed Web of Science ®Google Scholar
• Ladenheim D. Some factors affecting the properties and performance of dermatological patches. Ph.D. thesis CNAA. Brighton Polytechnic Department of Pharmacy, BrightonUK 1991
   Google Scholar
• Place V. A., Velazquez J. G., Burdick K. H. Precise evaluation of topically applied corticosteroid potency. Arch. Dermatol. 1970; 101: 531–537
   PubMed Web of Science ®Google Scholar
• Du Vivier A., Stoughton R. B. Tachyphylaxis to the action of topically applied corticosteroids. Arch. Dermatol. 1975; 111: 581–583
   PubMed Web of Science ®Google Scholar
• Cornell R. C., Stoughton R. B. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch. Dermatol. 1985; 121: 63–67
   PubMed Web of Science ®Google Scholar
• Stoughton R. B. Are generic formulations equivalent to trade name topical glucocorticoids. Arch. Dermatol. 1987; 123: 1312–1314
   PubMed Web of Science ®Google Scholar
• Barry B. W., Woodford R. Comparative bioavailability of proprietary topical corticosteroid preparations: vasoconstrictor assays on 30 creams and gels. Br. J. Dermatol. 1974; 91: 323–338
   PubMed Web of Science ®Google Scholar